7,211 followers
Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years. #CML . https://t.co/qFlMeCzG1N https://t.co/7l57dT0bjx
Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years. #CML . https://t.co/qFlMeCzG1N https://t.co/7l57dT0bjx